ULK1 inhibits the kinase activity of mTORC1 and cell proliferation

Chang Hwa Jung1, Minchul Seo, Neil Michael Otto

  • 1Department of Biochemistry, Molecular Biology and Biophysics; University of Minnesota, Minneapolis, MN, USA.

Autophagy
|July 29, 2011
PubMed

Insights

Unc51-like kinase 1 (ULK1) inhibits mTORC1 signaling and cell proliferation. ULK1 deficiency enhances mTORC1 activity and cell growth, independent of Atg5 and TSC2, suggesting a key role in energy utilization.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Unc51-like kinase 1 (ULK1) is a key regulator of autophagy induction.
  • ULK1 is known to be negatively regulated by the mammalian target of rapamycin complex 1 (mTORC1).
  • Previous research suggests ULK1 acts as both a downstream target and a negative regulator of mTORC1 signaling.

Purpose of the Study:

  • To investigate the mechanism by which ULK1 regulates mTORC1 signaling.
  • To determine the role of ULK1 in controlling cell proliferation and mTORC1 activity.

Main Methods:

  • Investigated ULK1 and ULK2 deficiency/knockdown effects on mTORC1 signaling and cell proliferation.
  • Examined the impact of Atg13 and Atg5 deficiency on mTORC1 signaling.
  • Assessed ULK1's interaction with raptor and its effect on mTORC1 kinase activity.
  • Studied ULK1's regulatory role in the presence and absence of TSC2.

Main Results:

  • ULK1 deficiency or knockdown enhanced mTORC1 signaling, cell proliferation, and cell mass accumulation.
  • Overexpression of ULK1 reduced mTORC1 signaling and cell proliferation.
  • Knockdown of Atg13 mimicked the effects of ULK1/ULK2 deficiency.
  • ULK1 directly binds raptor, phosphorylates it, and inhibits mTORC1 kinase activity, independent of Atg5 and TSC2.

Conclusions:

  • ULK1 acts as a negative regulator of mTORC1 kinase activity and cell proliferation.
  • This regulation occurs independently of Atg5 and TSC2.
  • ULK1's inhibition of mTORC1 is crucial for coordinating cell growth and autophagy for optimal energy use.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...